Showing results (661-670 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|April 27, 2016
The incremental prognostic and clinical value of multiple novel biomarkers in heart failureColette E Jackson, Caroline Haig, Paul Welsh, et al.
European Journal of Heart Failure|October 23, 2020
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosisMélanie Bézard, Mounira Kharoubi, Arnault Galat, et al.
European Journal of Heart Failure|November 22, 2020
Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysisGianluigi Savarese, Lina Benson, Johan Sundström, et al.
European Journal of Heart Failure|November 17, 2020
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterizationSergio Caravita, Claudia Baratto, Fabiano Di Marco, et al.
European Journal of Heart Failure|December 27, 2022
Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosisRishi K Patel, Adam Ioannou, Yousuf Razvi, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|January 24, 2023
Concomitant latent pulmonary vascular disease leads to impaired global cardiac performance in heart failure with preserved ejection fractionAndreas Schuster, Alexander Schulz, Torben Lange, et al.
European Journal of Heart Failure|January 16, 2023
Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomesDanielle M Gualandro, Christian Puelacher, Michelle S Chew, et al.
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
European Journal of Heart Failure|January 9, 2021
The advantages, pitfalls and limitations of guideline-directed medical therapy in patients with valvular heart diseaseHarminder Gill, Omar Chehab, Christopher Allen, et al.
Pageof 398